Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Sciatica by Adalimumab Injection
2006-001608-35Phase 4Completed
- Sponsor
- Dr. Valérie gangji
- Start
- Nov 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of adalimumab in Sciatica and Herniated Lumbar Disk (2 arms), sponsored by Dr. Valérie gangji. Primary endpoint: Global treatment success or failure at 1 week. Started Nov 2006; status: completed.
02
Drugs
03
Conditions
SciaticaHerniated Lumbar Disk
Beyond the preview
Go deeper on 2006-001608-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001608-35.